{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T02:17:31Z","timestamp":1768011451735,"version":"3.49.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Urol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11934-025-01306-z","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T05:01:53Z","timestamp":1765256513000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cost Consideration for the Treatment of Peyronie\u2019s Disease: A Narrative Review"],"prefix":"10.1007","volume":"26","author":[{"given":"Maxine","family":"Parkinson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ari P.","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew J.","family":"Ziegelmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,9]]},"reference":[{"key":"1306_CR1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.37037","author":"O Feyisetan","year":"2023","unstructured":"Feyisetan O. Peyronie\u2019s disease: a brief overview. Cureus. 2023. https:\/\/doi.org\/10.7759\/cureus.37037.","journal-title":"Cureus"},{"issue":"3","key":"1306_CR2","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.juro.2015.05.098","volume":"194","author":"A Nehra","year":"2015","unstructured":"Nehra A, Alterowitz R, Culkin DJ, Faraday MM, Hakim LS, Heidelbaugh JJ, Khera M, Kirkby E, McVary KT, Miner MM, Nelson CJ, Sadeghi-Nejad H, Seftel AD, Shindel AW, Burnett AL. Peyronie\u2019s disease: AUA guideline. J Urol. 2015;194(3):745\u201353. https:\/\/doi.org\/10.1016\/j.juro.2015.05.098.","journal-title":"J Urol"},{"issue":"1","key":"1306_CR3","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/s0022-5347(01)65361-8","volume":"157","author":"CJ Devine Jr","year":"1997","unstructured":"Devine CJ Jr, Somers KD, Jordan SG, Schlossberg SM. Proposal: trauma as the cause of the Peyronie\u2019s lesion. J Urol. 1997;157(1):285\u201390. https:\/\/doi.org\/10.1016\/s0022-5347(01)65361-8.","journal-title":"J Urol"},{"key":"1306_CR4","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1046\/j.1464-4096.2001.02436.x","volume":"88","author":"U Schwarzer","year":"2001","unstructured":"Schwarzer U, Sommer F, Klotz T, Braun M, Reifenrath B, Engelmann U. The prevalence of peyronie\u2019s disease: results of a large survey. BJU Int. 2001;88:727\u201330. https:\/\/doi.org\/10.1046\/j.1464-4096.2001.02436.x.","journal-title":"BJU Int"},{"issue":"4","key":"1306_CR5","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.esxm.2020.08.003","volume":"8","author":"CJ Loftus","year":"2020","unstructured":"Loftus CJ, Rajanahally S, Holt SK, Raheem OA, Ostrowski KA, Walsh TJ. Treatment trends and cost associated with peyronie\u2019s disease. Sex Med. 2020;8(4):673\u20138. https:\/\/doi.org\/10.1016\/j.esxm.2020.08.003.","journal-title":"Sex Med"},{"issue":"2","key":"1306_CR6","doi-asserted-by":"publisher","first-page":"e0150157","DOI":"10.1371\/journal.pone.0150157","volume":"11","author":"M Stuntz","year":"2016","unstructured":"Stuntz M, Perlaky A, des Vignes F, Kyriakides T, Glass D. The prevalence of peyronie\u2019s disease in the united states: A Population-Based study. PLoS ONE. 2016;11(2):e0150157. https:\/\/doi.org\/10.1371\/journal.pone.0150157.","journal-title":"PLoS ONE"},{"issue":"3","key":"1306_CR7","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.eururo.2012.05.040","volume":"62","author":"K Hatzimouratidis","year":"2012","unstructured":"Hatzimouratidis K, Eardley I, Giuliano F, Hatzichristou D, Moncada I, Salonia A, et al. EAU guidelines on penile curvature. Eur Urol. 2012;62(3):543\u201352. https:\/\/doi.org\/10.1016\/j.eururo.2012.05.040.","journal-title":"Eur Urol"},{"key":"1306_CR8","unstructured":"Peyronie\u2019s Disease. (n.d.). ISSM. Retrieved June 22. 2025, from https:\/\/www.issm.info\/sh-topics\/peyronie-s-disease"},{"issue":"3","key":"1306_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.esxm.2022.100517","volume":"10","author":"EL Walton","year":"2022","unstructured":"Walton EL, Quinn TP, Mulloy E, Patil D, Mehta A. Cost of intralesional collagenase clostridium histiolyticum therapy versus surgery for the management of peyronie\u2019s disease: a claims-based analysis (2009\u20132019). Sex Med. 2022;10(3):1\u20131. https:\/\/doi.org\/10.1016\/j.esxm.2022.100517.","journal-title":"Sex Med"},{"issue":"9","key":"1306_CR10","doi-asserted-by":"publisher","first-page":"e283","DOI":"10.1371\/journal.pmed.0040283","volume":"4","author":"GM Allan","year":"2007","unstructured":"Allan GM, Lexchin J, Wiebe N. Physician awareness of drug cost: a systematic review. PLoS Med. 2007;4(9):e283. https:\/\/doi.org\/10.1371\/journal.pmed.0040283.","journal-title":"PLoS Med"},{"issue":"1","key":"1306_CR11","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/SLA.0000000000003165","volume":"271","author":"DR Kaye","year":"2020","unstructured":"Kaye DR, Luckenbaugh AN, Oerline M, Hollenbeck BK, Herrel LA, Dimick JB, et al. Understanding the costs associated with surgical care delivery in the Medicare population. Ann Surg. 2020;271(1):23\u20138. https:\/\/doi.org\/10.1097\/SLA.0000000000003165.","journal-title":"Ann Surg"},{"key":"1306_CR12","unstructured":"CMS (2024). NHE Fact Sheet. Centers for Medicare & Medicaid Services. Retrieved June 15, 2025, from https:\/\/www.cms.gov\/data-research\/statistics-trends-and-reports\/national-health-expenditure-data\/nhe-fact-sheet"},{"key":"1306_CR13","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/s41585-021-00532-7","volume":"19","author":"A Sultana","year":"2022","unstructured":"Sultana A, Grice P, Vukina J, et al. Indications and characteristics of penile traction and vacuum erection devices. Nat Rev Urol. 2022;19:84\u2013100. https:\/\/doi.org\/10.1038\/s41585-021-00532-7.","journal-title":"Nat Rev Urol"},{"issue":"3","key":"1306_CR14","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1080\/2090598X.2021.1957411","volume":"19","author":"AT Mefford","year":"2021","unstructured":"Mefford AT, Raheem O, Yafi FA, Alzweri LM. Peyronie\u2019s disease \u2013 outcomes of collagenase clostridium histolyticum injection: a systematic review. Arab J Urol. 2021;19(3):363\u20139. https:\/\/doi.org\/10.1080\/2090598X.2021.1957411.","journal-title":"Arab J Urol"},{"issue":"3","key":"1306_CR15","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1097\/JU.0000000000000245","volume":"202","author":"M Ziegelmann","year":"2019","unstructured":"Ziegelmann M, Savage J, Toussi A, Alom M, Yang D, Kohler T, et al. Outcomes of a novel penile traction device in men with Peyronie\u2019s disease: a randomized, single-blind, controlled trial. J Urol. 2019;202(3):599\u2013610. https:\/\/doi.org\/10.1097\/JU.0000000000000245.","journal-title":"J Urol"},{"issue":"2","key":"1306_CR16","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/jsm.12400","volume":"11","author":"JI Mart\u00ednez-Salamanca","year":"2014","unstructured":"Mart\u00ednez-Salamanca JI, Egui A, Moncada I, Minaya J, Ballesteros CM, Del Portillo L, et al. Acute phase Peyronie\u2019s disease management with traction device: a nonrandomized prospective controlled trial with ultrasound correlation. J Sex Med. 2014;11(2):506\u201315. https:\/\/doi.org\/10.1111\/jsm.12400.","journal-title":"J Sex Med"},{"issue":"12","key":"1306_CR17","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1016\/j.jsxm.2020.10.003","volume":"17","author":"J Joseph","year":"2020","unstructured":"Joseph J, Ziegelmann MJ, Alom M, Savage J, K\u00f6hler TS, Trost L. Outcomes of RestoreX penile traction therapy in men with Peyronie\u2019s disease: results from open label and follow-up phases. J Sex Med. 2020;17(12):2462\u201371. https:\/\/doi.org\/10.1016\/j.jsxm.2020.10.003.","journal-title":"J Sex Med"},{"issue":"9","key":"1306_CR18","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1016\/j.jsxm.2019.06.010","volume":"16","author":"K Wymer","year":"2019","unstructured":"Wymer K, Kohler T, Trost L. Comparative cost-effectiveness of surgery, collagenase clostridium Histolyticum, and penile traction therapy in men with peyronie\u2019s disease in an era of effective clinical treatment. J Sex Med. 2019;16(9):1421\u201332. https:\/\/doi.org\/10.1016\/j.jsxm.2019.06.010.","journal-title":"J Sex Med"},{"key":"1306_CR19","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.urology.2017.01.054","volume":"104","author":"MJ Ziegelmann","year":"2017","unstructured":"Ziegelmann MJ, Viers BR, Montgomery BD, Avant RA, Savage JB, Trost LW. Clinical experience with penile traction therapy among men undergoing collagenase clostridium histolyticum for Peyronie disease. Urology. 2017;104:102\u20139. https:\/\/doi.org\/10.1016\/j.urology.2017.01.054.","journal-title":"Urology"},{"issue":"6","key":"1306_CR20","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1111\/jsm.12904","volume":"12","author":"MK Gelbard","year":"2015","unstructured":"Gelbard MK, Chagan L, Tursi JP. Collagenase clostridium histolyticum for the treatment of peyronie\u2019s disease: the development of this novel pharmacologic approach. J Sex Med. 2015;12(6):1481\u20139. https:\/\/doi.org\/10.1111\/jsm.12904.","journal-title":"J Sex Med"},{"key":"1306_CR21","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1111\/iju.14230","volume":"27","author":"MJ Ziegelmann","year":"2020","unstructured":"Ziegelmann MJ, Bajic P, Levine LA. Peyronie\u2019s disease: contemporary evaluation and management. Int J Urol. 2020;27:504\u201316. https:\/\/doi.org\/10.1111\/iju.14230.","journal-title":"Int J Urol"},{"issue":"8","key":"1306_CR22","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/s41443-021-00469-w","volume":"34","author":"A Cocci","year":"2022","unstructured":"Cocci A, Russo GI, Martinez-Salamanca JI, Ralph D, Djinovic R, \u015eerefo\u011flu EC, Mondaini N. Is there a line between ethics and market competition? Lights and shades of the withdrawal of collagenase treatment for peyronie\u2019s disease. Int J Impot Res. 2022;34(8):733\u20134. https:\/\/doi.org\/10.1038\/s41443-021-00469-w.","journal-title":"Int J Impot Res"},{"issue":"6","key":"1306_CR23","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/s41443-021-00458-z","volume":"34","author":"U Mann","year":"2022","unstructured":"Mann U, Shiff B, Jain K, Flannigan R, Elterman D, Patel P. Canadian provider perspectives on collagenase clostridium histolyticum for the treatment of peyronie\u2019s disease and the impact of its discontinuation. Int J Impot Res. 2022;34(6):599\u2013602. https:\/\/doi.org\/10.1038\/s41443-021-00458-z.","journal-title":"Int J Impot Res"},{"issue":"1","key":"1306_CR24","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.juro.2013.01.087","volume":"190","author":"M Gelbard","year":"2013","unstructured":"Gelbard M, Goldstein I, Hellstrom WJG, McMahon CG, Smith T, Tursi J, et al. Clinical efficacy, safety and tolerability of Collagenase Clostridium histolyticum for the treatment of Peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies. J Urol. 2013;190(1):199\u2013207. https:\/\/doi.org\/10.1016\/j.juro.2013.01.087.","journal-title":"J Urol"},{"key":"1306_CR25","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.urology.2023.10.022","volume":"183","author":"K Lehner","year":"2024","unstructured":"Lehner K, Byrne E, Roshandel MR, Alom M, Helo S, K\u00f6hler T, et al. The discontinuation rate with collagenase clostridium histolyticum for peyronie\u2019s disease in a high-volume practice is unexpectedly high: identifying opportunities for patient care improvement. Urology. 2024;183:121\u20136. https:\/\/doi.org\/10.1016\/j.urology.2023.10.022.","journal-title":"Urology"},{"issue":"2","key":"1306_CR26","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s00345-019-02791-x","volume":"38","author":"FM El-Khatib","year":"2020","unstructured":"El-Khatib FM, Towe M, Yafi FA. Management of peyronie\u2019s disease with collagenase clostridium histolyticum in the acute phase. World J Urol. 2020;38(2):299\u2013304. https:\/\/doi.org\/10.1007\/s00345-019-02791-x.","journal-title":"World J Urol"},{"key":"1306_CR27","doi-asserted-by":"publisher","unstructured":"Schardein J, Shonnard C, Jimbo M, Horns J, Das R, Hotaling J, Pastuszak A, Christensen B. (401) Treatment utilization and temporal trends in peyronie\u2019s disease: a retrospective analysis of an insurance claims database. J Sexual Med. 2024 21(Supplement_1), qdae001.386. https:\/\/doi.org\/10.1093\/jsxmed\/qdae001.386","DOI":"10.1093\/jsxmed\/qdae001.386"},{"issue":"5","key":"1306_CR28","doi-asserted-by":"publisher","first-page":"qfae071","DOI":"10.1093\/sexmed\/qfae071","volume":"12","author":"N Hricz","year":"2024","unstructured":"Hricz N, Schlidt K, Ha M, Er S, Stark K, Jung E, Liang F, Rasko YM. A review of peyronie\u2019s disease insurance coverage. Sex Med. 2024;12(5):qfae071. https:\/\/doi.org\/10.1093\/sexmed\/qfae071.","journal-title":"Sex Med"},{"issue":"5","key":"1306_CR29","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1097\/JU.0000000000003634","volume":"210","author":"B Green","year":"2023","unstructured":"Green B, Flores A, Warner J, Kohler T, Helo S, Trost L. Comparison of collagenase clostridium histolyticum to surgery for the management of peyronie\u2019s disease: a randomized trial. J Urol. 2023;210(5):791\u2013802. https:\/\/doi.org\/10.1097\/JU.0000000000003634.","journal-title":"J Urol"},{"issue":"2","key":"1306_CR30","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.urpr.2016.04.005","volume":"4","author":"BH Cordon","year":"2017","unstructured":"Cordon BH, Hofer MD, Hutchinson RC, Broderick GA, Lotan Y, Morey AF. Superior cost effectiveness of penile plication vs intralesional collagenase injection for treatment of peyronie\u2019s disease deformities. Urol Pract. 2017;4(2):118\u201325. https:\/\/doi.org\/10.1016\/j.urpr.2016.04.005.","journal-title":"Urol Pract"},{"key":"1306_CR31","doi-asserted-by":"publisher","unstructured":"Patel H. Surgical Management of Peyronie\u2019s Disease, European Urology Focus, Volume 4, Issue 3, 2018, Pages 304\u2013306, ISSN 2405\u20134569. https:\/\/doi.org\/10.1016\/j.euf.2018.08.026","DOI":"10.1016\/j.euf.2018.08.026"},{"issue":"4","key":"1306_CR32","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1097\/UPJ.0000000000000588","volume":"11","author":"DS Bal","year":"2024","unstructured":"Bal DS, Fidel M, Shah J, Urichuk M, Sidhom K, Pandian A, Bard R, Patel P. Prospective pilot study: tolerability of outpatient penile plication under Nursing-Administered conscious sedation vs Anesthesiologist-Administered deep sedation. Urol Pract. 2024;11(4):662\u20138. https:\/\/doi.org\/10.1097\/UPJ.0000000000000588.","journal-title":"Urol Pract"},{"issue":"1","key":"1306_CR33","doi-asserted-by":"publisher","first-page":"174","DOI":"10.21037\/tau-20-871","volume":"10","author":"CJ Britton","year":"2021","unstructured":"Britton CJ, Findlay BL, Parikh N, Kohler T, Helo S, Ziegelmann MJ. Long-acting liposomal bupivacaine and postoperative opioid use after peyronie\u2019s disease surgery: a pilot study. Transl Androl Urol. 2021;10(1):174\u201383. https:\/\/doi.org\/10.21037\/tau-20-871.","journal-title":"Transl Androl Urol"},{"issue":"1","key":"1306_CR34","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/andr.12421","volume":"6","author":"B Garcia-Gomez","year":"2018","unstructured":"Garcia-Gomez B, Ralph D, Levine L, Moncada-Iribarren I, Djinovic R, Albersen M, Garcia-Cruz E, Romero-Otero J. Grafts for peyronie\u2019s disease: a comprehensive review. Andrology. 2018;6(1):117\u201326. https:\/\/doi.org\/10.1111\/andr.12421.","journal-title":"Andrology"},{"issue":"2","key":"1306_CR35","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s00345-019-02792-w","volume":"38","author":"G Hatzichristodoulou","year":"2020","unstructured":"Hatzichristodoulou G. Evolution of the surgical sealing patch TachoSil\u00ae in peyronie\u2019s disease reconstructive surgery: technique and contemporary literature review. World J Urol. 2020;38(2):315\u201321. https:\/\/doi.org\/10.1007\/s00345-019-02792-w.","journal-title":"World J Urol"},{"issue":"3","key":"1306_CR36","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/s41443-020-00401-8","volume":"34","author":"I Sokolakis","year":"2022","unstructured":"Sokolakis I, Pyrgidis N, Hatzichristodoulou G. The use of collagen fleece (TachoSil) as grafting material in the surgical treatment of peyronie\u2019s disease. A comprehensive narrative review. Int J Impot Res. 2022;34(3):260\u20138. https:\/\/doi.org\/10.1038\/s41443-020-00401-8.","journal-title":"Int J Impot Res"},{"key":"1306_CR37","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/ijir.2013.7","volume":"25","author":"G Hatzichristodoulou","year":"2013","unstructured":"Hatzichristodoulou G, Gschwend J, Lahme S. Surgical therapy of peyronie\u2019s disease by partial plaque excision and grafting with collagen fleece: feasibility study of a new technique. Int J Impot Res. 2013;25:183\u20137. https:\/\/doi.org\/10.1038\/ijir.2013.7.","journal-title":"Int J Impot Res"},{"issue":"2","key":"1306_CR38","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.sxmr.2020.01.005","volume":"9","author":"C Natale","year":"2021","unstructured":"Natale C, McLellan DM, Yousif A, Hellstrom WJG. Review of intralesional collagenase clostridium histolyticum injection therapy and related combination therapies in the treatment of peyronie\u2019s disease (an update). Sex Med Rev. 2021;9(2):340\u20139. https:\/\/doi.org\/10.1016\/j.sxmr.2020.01.005.","journal-title":"Sex Med Rev"},{"key":"1306_CR39","doi-asserted-by":"publisher","unstructured":"Manaf Alom KL, Sharma A, Toussi T, Kohler L, Trost. Efficacy of combined collagenase Clostridium histolyticum and restorex penile traction therapy in men with peyronie\u2019s disease. J Sex Med. 2019;16:891\u2013900. https:\/\/doi.org\/10.1016\/j.jsxm.2019.03.007.","DOI":"10.1016\/j.jsxm.2019.03.007"},{"key":"1306_CR40","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.urology.2023.01.061","volume":"178","author":"J Thomas","year":"2023","unstructured":"Thomas J, Sencaj M, Ghomeshi A, Zucker IJ, Best JC, Ramasamy R. Stem-cell, shockwave, and platelet rich plasma therapy for the treatment of erectile dysfunction and peyronie\u2019s disease: A survey of clinics across the USA. Urology. 2023;178:83\u201390. https:\/\/doi.org\/10.1016\/j.urology.2023.01.061.","journal-title":"Urology"},{"issue":"11","key":"1306_CR41","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1016\/j.jsxm.2022.08.001","volume":"19","author":"JM Flores","year":"2022","unstructured":"Flores JM, Nascimento B, Punjani N, Salter CA, Bernie HL, Taniguchi H, Miranda E, Terrier J-E, Schofield E, Jenkins L, Mulhall JP. Predictors of curvature improvement in men with peyronie\u2019s disease treated with intralesional collagenase clostridium histolyticum. J Sex Med. 2022;19(11):1680\u20136. https:\/\/doi.org\/10.1016\/j.jsxm.2022.08.001.","journal-title":"J Sex Med"},{"issue":"3","key":"1306_CR42","doi-asserted-by":"publisher","first-page":"A157","DOI":"10.1016\/j.jval.2014.03.918","volume":"17","author":"Y Ding","year":"2014","unstructured":"Ding Y, Hay JW. Economic burden associated with patients diagnosed with peyronie\u2019s disease in the united States. Value Health. 2014;17(3):A157\u20138. https:\/\/doi.org\/10.1016\/j.jval.2014.03.918.","journal-title":"Value Health"}],"container-title":["Current Urology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-025-01306-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11934-025-01306-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-025-01306-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T19:04:44Z","timestamp":1767985484000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11934-025-01306-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1306"],"URL":"https:\/\/doi.org\/10.1007\/s11934-025-01306-z","relation":{},"ISSN":["1527-2737","1534-6285"],"issn-type":[{"value":"1527-2737","type":"print"},{"value":"1534-6285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"3 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All reported studies\/experiments with human or animal subjects performed by the authors were performed in accordance with all applicable ethical standards including the Helsinki declaration and its amendments, institutional\/national research committee standards, and international\/national\/institutional guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"78"}}